Withdrawal of Antithrombotic Agents and the Risk of Stroke.

TGF-β1/Smad3 Signaling Pathway Suppresses Cell Apoptosis in Cerebral Ischemic Stroke Rats. Med Sci Monit (2017) 0.75

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ (2002) 20.22

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet (2007) 10.10

Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08

Deaths: final data for 2010. Natl Vital Stat Rep (2013) 5.95

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

Management of anticoagulation before and after elective surgery. N Engl J Med (1997) 5.10

Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med (2008) 4.83

Public perception of stroke warning signs and knowledge of potential risk factors. JAMA (1998) 4.21

Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med (2005) 2.98

Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol (2005) 2.60

Trends in community knowledge of the warning signs and risk factors for stroke. JAMA (2003) 2.40

Managing oral anticoagulant therapy. Chest (2001) 2.25

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). J Am Coll Cardiol (2013) 2.17

Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2013) 2.15

Discontinuation and reinstitution of medications during the perioperative period. Am J Health Syst Pharm (2004) 1.98

Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology (2011) 1.97

Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology (2011) 1.93

Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology (2004) 1.88

Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke (2010) 1.62

Perioperative care of patients at high risk for stroke during or after non-cardiac, non-neurologic surgery: consensus statement from the Society for Neuroscience in Anesthesiology and Critical Care*. J Neurosurg Anesthesiol (2014) 1.44

Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 1.39

Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence. Stroke (2011) 1.17

REBOUND PHENOMENA AFTER ANTICOAGULANT THERAPY IN CEREBROVASCULAR DISEASE. Circulation (1963) 1.13

Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol (1996) 1.07

Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study. Cerebrovasc Dis (2013) 0.98

Perioperative management of warfarin and antiplatelet therapy. Cleve Clin J Med (2009) 0.96

Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol (2005) 0.96

Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations. JAMA (1978) 0.90

Blood loss in long-term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol (1996) 0.89

Discontinuation of rivaroxaban: filling in the gaps. J Am Coll Cardiol (2013) 0.87

Thromboembolic complications several days after a single-dose administration of aspirin. Thromb Res (1998) 0.84

Inter-individual variations of the effect of low dose aspirin regime on platelet cyclooxygenase activity. Thromb Res (1994) 0.84

Perioperative stroke risk in nonvascular surgery. Cerebrovasc Dis (2012) 0.81

Anticoagulation in neurosurgical patients. Neurosurgery (1999) 0.81

The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis (2004) 0.80

Withdrawal of warfarin prior to a surgical procedure: time to follow the guidelines? Cerebrovasc Dis (2005) 0.78

Risk associated with heparin withdrawal in ischaemic cerebrovascular disease. J Neurol Neurosurg Psychiatry (1989) 0.77

Discontinuation of perioperative antiplatelet and anticoagulant therapy in stroke patients. Neurol Clin (2006) 0.77

Effect of warfarin withdrawal on thrombolytic treatment in patients with ischaemic stroke. Eur J Neurol (2011) 0.77

Food-specific serum immunoglobulin E measurements in children presenting with food allergy. Ann Allergy Asthma Immunol (2013) 0.79

Longitudinal Patterns of Glycemic Control and Blood Pressure in Pregnant Women with Type 1 Diabetes Mellitus: Phenotypes from Functional Data Analysis. Am J Perinatol (2016) 0.78

Characterizing Gestational Weight Gain According to Institute of Medicine Guidelines in Women with Type 1 Diabetes Mellitus: Association with Maternal and Perinatal Outcome. Am J Perinatol (2016) 0.75